Ipilimumab vs Sildenafil
Ipilimumab vs Sildenafil: Overview
This comparison examines the pharmacological differences between Ipilimumab and Sildenafil.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Sildenafil: Selective PDE5 inhibitor increasing cGMP.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Sildenafil — 4 hours.
Chemical Properties
Molecular Formula: Sildenafil — C22H30N6O4S.
Molecular Weight: Sildenafil — 474.5800 g/mol.
Type: Ipilimumab — Antibody; Sildenafil — Small molecule.